{
  "trial_id": "NCT00125762",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "scheduled for liver biopsy prior to treatment",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "off treatment for at least three months",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "time between FibroScan reading and biopsy not exceed six months",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "sample size of 300 evaluable patients",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "subject able to give informed consent",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "subject at least 18 years old",
      "label": "met",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "unable or unwilling to provide informed consent",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "confirmed diagnosis and/or history of malignancy",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "uninterpretable biopsy specimen",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "receiving anti-viral therapy for HCV or HBV within 3 months prior to FibroScan and liver biopsy",
      "label": "not_met",
      "evidence": ""
    }
  ],
  "notes": "",
  "_meta": {
    "topic_id": "64",
    "trial_id": "NCT00125762",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}